Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?

Improvement of insulin secretion by pancreatic β-cells and preservation of their mass are the current challenges that future antidiabetic drugs should meet for achieving efficient and long-term glycemic control in patients with type 2 diabetes (T2D). The successful development of glucagon-like pepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodato, Michele, Plaisance, Valérie, Pawlowski, Valérie, Kwapich, Maxime, Barras, Alexandre, Buissart, Emeline, Dalle, Stéphane, Szunerits, Sabine, Vicogne, Jérôme, Boukherroub, Rabah, Abderrahmani, Amar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047094/
https://www.ncbi.nlm.nih.gov/pubmed/36980281
http://dx.doi.org/10.3390/cells12060940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047094/
https://www.ncbi.nlm.nih.gov/pubmed/36980281
http://dx.doi.org/10.3390/cells12060940

Ejemplares similares